Charles M. Fernandez - Jul 1, 2023 Form 4 Insider Report for Progressive Care Inc. (RXMD)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Charles M. Fernandez
Stock symbol
RXMD
Transactions as of
Jul 1, 2023
Transactions value $
$506,001
Form type
4
Date filed
10/20/2023, 12:04 PM
Previous filing
Jun 30, 2023
Next filing
Apr 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXMD Common Stock Exercise of in-the-money or at-the-money derivative security $502K +228K +17.17% $2.20 1.56M Jul 1, 2023 By eAperion Partners LLC F7, F8
transaction RXMD Common Stock Sale -$502K -113K -7.25% $4.45 1.44M Jul 1, 2023 By eAperion Partners LLC F1, F7
transaction RXMD Common Stock Exercise of in-the-money or at-the-money derivative security $418K +190K +13.15% $2.20 1.63M Jul 1, 2023 By eAperion Partners LLC F7
transaction RXMD Common Stock Sale -$418K -93.9K -5.75% $4.45 1.54M Jul 1, 2023 By eAperion Partners LLC F2, F7
transaction RXMD Common Stock Exercise of in-the-money or at-the-money derivative security $1M +455K +29.53% $2.20 2M Jul 1, 2023 By NextPlat Corp F6
transaction RXMD Common Stock Sale -$1M -225K -11.27% $4.45 1.77M Jul 1, 2023 By NextPlat Corp F3, F6
transaction RXMD Common Stock Exercise of in-the-money or at-the-money derivative security $749K +341K +19.24% $2.20 2.11M Jul 1, 2023 By NextPlat Corp F6
transaction RXMD Common Stock Sale -$749K -168K -7.98% $4.45 1.94M Jul 1, 2023 By NextPlat Corp F4, F6
transaction RXMD Common Stock Exercise of in-the-money or at-the-money derivative security $506K +230K +11.84% $2.20 2.17M Jul 1, 2023 By NextPlat Corp F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXMD Common Stock Warrant Exercise of in-the-money or at-the-money derivative security $0 +228K $0.00* 0 Jul 1, 2023 Common Stock 228K $2.20 By eAperion Partners LLC F7
transaction RXMD Common Stock Warrant Exercise of in-the-money or at-the-money derivative security $0 +190K $0.00* 0 Jul 1, 2023 Common Stock 190K $2.20 By eAperion Partners LLC F7
transaction RXMD Common Stock Warrant Exercise of in-the-money or at-the-money derivative security $0 +455K $0.00* 0 Jul 1, 2023 Common Stock 455K $2.20 By NextPlat Corp F6
transaction RXMD Common Stock Warrant Exercise of in-the-money or at-the-money derivative security $0 +341K $0.00* 0 Jul 1, 2023 Common Stock 341K $2.20 By NextPlat Corp F6
transaction RXMD Common Stock Warrant Exercise of in-the-money or at-the-money derivative security $0 +230K $0.00* 0 Jul 1, 2023 Common Stock 230K $2.20 By NextPlat Corp F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 1, 2023, eAperion Partners, LLC exercised a Conversion Warrant to purchase 228,240 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 112,838 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 115,402 shares.
F2 On July 1, 2023, eAperion Partners, LLC exercised an Inducement Warrant to purchase 190,000 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 93,932 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 96,068 shares.
F3 On July 1, 2023, NextPlat Corp exercised a Warrant to purchase 455,000 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 224,944 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 230,056 shares.
F4 On July 1, 2023, NextPlat Corp exercised a Conversion Warrant to purchase 340,599 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 168,386 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 172,213 shares.
F5 On July 1, 2023, NextPlat Corp, exercised a Conversion Warrant to purchase 230,000 shares of RXMD common stock for $2.20 per share. NextPlat Corp paid the exercise price on a cash basis.
F6 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F7 The Reporting Person is the sole member and managing member of eAperion Partners LLC.
F8 Includes 18,261 shares of common stock directly held by the Reporting Person; 1,071,251 shares of common stock held indirectly by NextPlat Corp., of which the Reporting Person is the Chief Executive Officer; and 239,604 shares of common stock held indirectly by eAperion Partners LLC, of which the Reporting person is the sole member and managing member.